GLORIA

GEOMAR Library Ocean Research Information Access

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    In: Annals of the Rheumatic Diseases, BMJ, Vol. 79, No. Suppl 1 ( 2020-06), p. 93.2-94
    Abstract: Giant cell arteritis (GCA) is the most common form of systemic vasculitis in patients aged 50 years and older. 1 Visual symptoms such as amaurosis, diplopia, temporary or permanent visual field loss secondary to optic nerve ischemia are common manifestations. 2 The value of vascular ultrasound of extra-ocular vessels in diagnosing GCA is well established. 3 However, the role of transocular ultrasound of the central retinal artery in GCA patients has not yet been established. Objectives: To identify changes in flow velocities of the central retinal artery in GCA patients with visual symptoms and controls with transocular high resolution ultrasound. Methods: Prospective analysis of GCA patients with visual symptoms and controls. Ultrasound of the central retinal artery was performed in 18 newly diagnosed consecutive GCA patients with visual symptoms (GCA-group) and 25 controls without ocular pathology. Visual symptoms included amaurosis, diplopia and temporary or permanent visual field loss. For each eye, peak systolic values (PS) and end diastolic values (ED) were recorded. Furthermore, the resistance index of each central retinal artery was measured. Results: Twenty-one of 36 eyes of 18 GCA patients were affected. Therefore 21 central retinal were measured. The control group consisted of 50 central retinal arteries of 25 eye-healthy individuals. The mean age and gender distribution of the GCA-group were 75.6 years (SD± 8.1) with eight females (44 %) and 67 years (SD± 8.9) with twelve females (48%) in the control group. The mean flow velocity of the central retinal artery was PS 12.2 cm/s (SD± 3.5) and ED 3.7 cm/s (SD± 1.2) in the GCA group and PS 14.4 cm/s (SD± 3.2) and ED 5.1 cm/s (SD± 1.6) in the control group. The mean RI was 0.9 (SD± 0.3) in the GCA group and 0.8 (SD± 0.3) in the control group. Mean reduction in flow velocity in the GCA-group was PS 2.1 cm/s (p= 0.039) and ED 1.4 (p= 0.0004) cm/s, while the RI was increased by 0.14 (p= 0.077). The results for PS and ED measurements were statistically significant, while the results for RI were not significant. Conclusion: In GCA patients with ocular symptoms, a reduction of flow velocities of the central retinal artery compared to the eye-healthy control group was found. Results for PS and ED were significant. There seems to be a trend for decreased flow velocities in coexistence with visual symptoms in patients with GCA. References: [1]Warrington KJ, Matteson EL. Management guidelines and outcome measures in giant cell arteritis (GCA). Clin Exp Rheumatol 2007;25:137–41. [2]Chean CS, Prior JA, Helliwell T, et al. Characteristics of patients with giant cell arteritis who experience visual symptoms. Rheumatol Int 2019;39:1789–96. [3]Dejaco C, Ramiro S, Duftner C, et al. EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice. Ann Rheum Dis 2018;77:636–43 Figure 1. Transocular ultrasound of an affected eye in giant cell arteritis with reduced flow velocities and increased resistance index. Disclosure of Interests: None declared
    Type of Medium: Online Resource
    ISSN: 0003-4967 , 1468-2060
    RVK:
    Language: English
    Publisher: BMJ
    Publication Date: 2020
    detail.hit.zdb_id: 1481557-6
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 2
    Online Resource
    Online Resource
    BMJ ; 2020
    In:  Annals of the Rheumatic Diseases Vol. 79, No. Suppl 1 ( 2020-06), p. 1070.2-1070
    In: Annals of the Rheumatic Diseases, BMJ, Vol. 79, No. Suppl 1 ( 2020-06), p. 1070.2-1070
    Abstract: Giant cell arteritis (GCA) is the most common form of systemic vasculitis affecting people aged 50 years and older. 1 Although it is known, that GCA often coexists with polymyalgia rheumatica (PMR) 2 , prevalence of GCA in consecutive patients with PMR has not been investigated Objectives: To prospectively examine the prevalence of GCA in consecutive patients with PMR by vascular ultrasound (US). Methods: Patients with newly diagnosed PMR fulfilling the ACR /EULAR classification criteria 3 were included. Vascular US examination of the extracranial arteries typically involved in GCA, such as axillary arteries, vertebral arteries, common carotid arteries, superficial temporal arteries with both frontal and parietal branches, occipital arteries, facial arteries and the central retinal arteries was performed in all PMR patients. Diagnosis of GCA was made, if intima-media thickness (IMT) was above respective cut-off values. 4 Results: Fifty patients with diagnosis of PMR underwent vascular US. Twenty-three patients (46%) had PMR without GCA (PMR-group). The mean age in this group was 71 years (SD ± 10) with seventeen (73%) females. In twenty-seven PMR patients (54%) GCA was diagnosed (GCA-PMR group); the mean age in this group was 74 years (SD ± 9) with ten (37%) females respectively. Mean C-reactive protein (CRP) values were 29.4 mg/l (SD±24.5) in the PMR-group and 52.2 mg/l (SD±43.2) in the GCA-PMR-group. Although different mean values between the PMR-group and the GCA-PMR-group were observed, CRP values did not differ significantly between the two groups (p = 0.1432). Ten (37%) patients of the GCA-PMR group did not have GCA symptoms and diagnosis of GCA was only determined by ultrasound examination. Symptoms and numbers of patients with respective symptoms are depicted in Table 1 and 2. Table 1. Symptoms and signs in both groups Symptoms and signs Group PMR-group GCA-PMR-group Morning stiffness 22 (95%) 23 (85%) ≥1 shoulder with synovits or bursitis trochanterica 12 (52%) 13 (48%) ≥1 shoulder or hip with synovitis or bursitis 11 (48%) 14 (51%) hip pain 23 (100%) 23 (85%) No other joints affected 22 (95%) 26 (96%) PMR-group: patients with diagnosis of polymyalgia rheumatica only GCA-PMR-group: patients with diagnosis of polymyalgia rheumatic and giant cell arteritis Conclusion: Prevalence of GCA in patients with PMR in our cohort was 54%. Ten (37%) patients with GCA and PMR did not have any GCA symptoms. Performing vascular US in patients with PMR can be useful to diagnose a clinical inapparent GCA. Prompt onset of the respective therapy could prevent complications of GCA and improve disease outcome. References: [1]Warrington KJ, Matteson EL. Management guidelines and outcome measures in giant cell arteritis (GCA). Clin Exp Rheumatol 2007;25:137–41 [2]Salvarani C, Cantini F, Hunder GG. Polymyalgia rheumatica and giant-cell arteritis. The Lancet 2008;372:234–45. [3]Dasgupta B, Cimmino MA, Kremers HM, et al. 2012 Provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative. Arthritis Rheum 2012;64:943–54. [4]Schäfer VS, Juche A, Ramiro S, Krause A, Schmidt WA. Ultrasound cut-off values for intima-media thickness of temporal, facial and axillary arteries in giant cell arteritis. Rheumatology (Oxford) 2017;56:1479–83. Table 2. Number of patients in each group with symptoms of giant cell arteritis Symptoms Group PMR-group GCA-PMR-group Visual symptoms 2 (9%) 8(30%) Headache 2 (9%) 9 (33%) Jaw claudication 4 (18%) 10 (38%) Scalp tenderness 0 (0%) 5 (19%) No GCA symptoms 15 (65%) 10 (37%) PMR-group: patients with diagnosis of polymyalgia rheumatica only GCA-PMR-group: patients with diagnosis of polymyalgia rheumatic and giant cell arteritis Disclosure of Interests: None declared
    Type of Medium: Online Resource
    ISSN: 0003-4967 , 1468-2060
    RVK:
    Language: English
    Publisher: BMJ
    Publication Date: 2020
    detail.hit.zdb_id: 1481557-6
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 3
    Online Resource
    Online Resource
    BMJ ; 2020
    In:  Annals of the Rheumatic Diseases Vol. 79, No. Suppl 1 ( 2020-06), p. 1531.3-1531
    In: Annals of the Rheumatic Diseases, BMJ, Vol. 79, No. Suppl 1 ( 2020-06), p. 1531.3-1531
    Abstract: Giant cell arteritis (GCA) and polymyalgia rheumatica (PMR) often coexist. 1 The role of modern ultrasound in diagnosis of GCA as well as PMR is well known. 2 To date it is unknown, whether patients with GCA and PMR have a different vasculitis pattern in ultrasound (US) examination than patients with GCA only. Objectives: To prospectively identify differences in vasculitis patterns in consecutive patients with newly diagnosed GCA and PMR compared to newly diagnosed GCA patients without PMR. Methods: US examination of the arteries typically affected in GCA, such as axillary arteries, vertebral arteries, superficial temporal arteries with both frontal and parietal branches and facial arteries was performed in patients with GCA and PMR (GCA-PMR-group) as well as in patients with GCA only (GCA-group) at time of first diagnosis. Arteries were defined as pathological, if measured intima-media-thickness by US was above respective cut-off values. 3 Results: The GCA-PMR-group consisted of 27 patients, the GCA-group of 18 patients. In the GCA-PMR-group, a total of 206 arteries were affected, while in the GCA-group 131 arteries were affected. Mean age and gender distribution was 74 years (SD± 9) with 10 (37%) females in the GCA-PMR-group and 76 years (SD± 9) with 10 (55%) females in the GCA-group. Median values of C-reactive protein (CRP) were 57.2 (IQR 31.7-75.7) in the GCA-group and 48.3 (IQR 17.5- 79.9) in the GCA-PMR-group, no significance was observed (p= 0.3577). Mean number of affected arteries per patient was 7.63 and 7.28 in the GCA-PMR-group and GCA-group, respectively. Altogether, no significant difference in vascular pattern between the two groups was observed. Exact numbers, distribution and IMT-values for all measured arteries are depicted in table 1. Conclusion: In our cohort, we did not observe a significant difference in vascular patterns between patients with GCA and PMR and GCA only patients. References: [1] Salvarani C, Cantini F, Hunder GG. Polymyalgia rheumatica and giant-cell arteritis. The Lancet 2008;372:234–45. [2] Dejaco C, Ramiro S, Duftner C, et al. EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice. Ann Rheum Dis 2018;77:636–43. [3] Schäfer VS, Juche A, Ramiro S, Krause A, Schmidt WA. Ultrasound cut-off values for intima-media thickness of temporal, facial and axillary arteries in giant cell arteritis. Rheumatology (Oxford) 2017;56:1479–83. Disclosure of Interests: None declared
    Type of Medium: Online Resource
    ISSN: 0003-4967 , 1468-2060
    RVK:
    Language: English
    Publisher: BMJ
    Publication Date: 2020
    detail.hit.zdb_id: 1481557-6
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 4
    In: Annals of the Rheumatic Diseases, BMJ, Vol. 79, No. Suppl 1 ( 2020-06), p. 196.2-196
    Abstract: Differentiation of gout and calcium pyrophosphate deposition disease (CPPD) is sometimes difficult as patients often present with a similar clinical picture. Arthrocentesis and subsequent polarization microscopy (PM) remains the gold standard but novel diagnostic approaches such as non-invasive dual energy computed tomography (DECT) have recently been validated for gout. Currently, limited data is available on DECT in patients with CPPD. Objectives: To analyse the diagnostic impact of DECT in gout and CPPD when compared to the gold standard of PM. We further compared the results of PM to ultrasound (US), conventional radiographs (CR), and suspected clinical diagnosis (SCD). Additionally, 15 laboratory parameters were analysed. Methods: Twenty-six patients diagnosed with gout (n = 18) or CPPD (n = 8) who received a DECT and underwent arthrocentesis were included. Two independent readers assessed colour coded, as well as 80 and 120 kV DECT images for signs of monosodium urate (MSU) crystals or CPP deposition. US and CR from the patient’s initial visit along with the SCD were also compared to PM. US examinations were performed by certified musculoskeletal ultrasound specialists. The association of up to 15 laboratory parameters such as uric acid, thyroid stimulating hormone, and C-reactive protein (CRP) with the PM results was analysed. Results: Sensitivity of DECT for gout was 67% (95% CI 0.41-0.87) with a specificity of 88% (95% CI 0.47-1.0). Concerning CPPD, the sensitivity and specificity of DECT was 63% (95% CI 0.25-0.91) and 83% (95% CI 0.59-0.96) respectively. US had the highest sensitivity of 89% (95% CI 0.65-0.99) with a specificity of 75% (95% CI 0.35-0.97) for gout, while the sensitivity and specificity for CPPD were 88% (95% CI 0.47-1.0) and 89% (95% CI 0.65-0.99) respectively. The SCD had the second highest sensitivity for gout at 78% (95% CI 0.52-0.94) with a comparable sensitivity of 63% (95% CI 0.25-0.92) for CPPD. Uric acid levels were elevated in 33% of gout patients and 25% of CPPD patients. While elevated CRP levels were observed in 59% of gout patients and in 88% of CPPD patients, none of the 15 analysed laboratory parameters were found to be significantly linked. Conclusion: DECT provides a non-invasive diagnostic tool for gout but might have a lower sensitivity than suggested by previous studies (67% vs 90% 1 ). DECT sensitivity for CPPD was 63% (95% CI 0.25-0.91) in a sample group of eight patients. Both US and the SCD had higher sensitivities than DECT for gout and CPPD. Further studies with larger patient cohorts are needed in order to determine the diagnostic utility of DECT in CPPD. References: [1]Bongartz, Tim; Glazebrook, Katrina N.; Kavros, Steven J.; Murthy, Naveen S.; Merry, Stephen P.; Franz, Walter B. et al. (2015): Dual-energy CT for the diagnosis of gout: an accuracy and diagnostic yield study. In Annals of the rheumatic diseases 74 (6), pp. 1072–1077. DOI: 10.1136/annrheumdis-2013-205095. Disclosure of Interests: None declared
    Type of Medium: Online Resource
    ISSN: 0003-4967 , 1468-2060
    RVK:
    Language: English
    Publisher: BMJ
    Publication Date: 2020
    detail.hit.zdb_id: 1481557-6
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 5
    Online Resource
    Online Resource
    Informa UK Limited ; 2023
    In:  Scandinavian Journal of Rheumatology Vol. 52, No. 1 ( 2023-01-02), p. 51-59
    In: Scandinavian Journal of Rheumatology, Informa UK Limited, Vol. 52, No. 1 ( 2023-01-02), p. 51-59
    Type of Medium: Online Resource
    ISSN: 0300-9742 , 1502-7732
    RVK:
    Language: English
    Publisher: Informa UK Limited
    Publication Date: 2023
    detail.hit.zdb_id: 1497111-2
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 6
    In: Annals of the Rheumatic Diseases, BMJ, Vol. 81, No. Suppl 1 ( 2022-06), p. 1033.2-1034
    Abstract: Joint effusion and enthesitis are common ultrasound findings in rheumatologic diseases like rheumatoid arthritis or spondyloarthritis. Physically active individuals and athletes were also found to exhibit structural and vascular changes in their entheses, as well as joint effusion through different imaging approaches [1, 2]. Objectives The aim of this study was to evaluate the development of joint and entheseal ultrasound findings in large and medium joints of young healthy individuals after one hour of standardised weight training. Methods A total of three musculoskeletal ultrasound examinations were performed in healthy individuals under the age of 30 years. The first examination was carried out before the individuals conducted one hour of standardized weight training, the second examination 24 hours later and the third examination 48 hours later. The examination comprised shoulder, elbow, wrist, hip, knee, and ankle joints, as well as associated entheseal sites. Poisson mixed effects models were applied to analyse the development of the ultrasound findings within 48 hours after the weight training. Results Fifty-one healthy individuals with a mean age of 23.7 years (± 2.5, range: 19-30) (52.9% female) were enrolled in this study. Fourteen participants (27.5%) presented with at least one abnormal enthesis at baseline, increasing to 24 (47.1%) after 24 hours and to 29 (56.9%) 48 hours after the weight training. Hyperperfusion was the only entheseal pathology detected by ultrasound after the training. The number of individuals with at least one joint effusion increased from 37 (72.6%) at baseline to 45 (88.2%) after 24 hours and to 48 (94.1%) 48 hours after the weight training. The Poisson mixed effects models showed a significant increase of the number of joints with effusion and entheses with pathologies with time after the weight training (p 〈 0.001, Exp(b) = 1.63 and p 〈 0.001, Exp(b) = 1.58). Conclusion Prevalence of joint effusion in large and medium joints as well as the prevalence of entheseal pathology increase significantly within 48 hours after one hour of weight training. As a result, the individual’s physical activity should be considered when performing a musculoskeletal ultrasound examination. References [1]Méric J-C, Grandgeorge Y, Lotito G, Pham T. Walking Before an Ultrasound Assessment Increases the Enthesis Score Significantly. J Rheumatol. 2011 May;38(5):961–961. [2]Lohman M, Kivisaari A, Vehmas T, Kallio P, Malmivaara A, Kivisaari L. MRI abnormalities of foot and ankle in asymptomatic, physically active individuals. Skeletal Radiol. 2001 Mar 5;30(2):61–6. Disclosure of Interests None declared
    Type of Medium: Online Resource
    ISSN: 0003-4967 , 1468-2060
    RVK:
    Language: English
    Publisher: BMJ
    Publication Date: 2022
    detail.hit.zdb_id: 1481557-6
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 7
    Online Resource
    Online Resource
    BMJ ; 2020
    In:  Annals of the Rheumatic Diseases Vol. 79, No. Suppl 1 ( 2020-06), p. 875.1-876
    In: Annals of the Rheumatic Diseases, BMJ, Vol. 79, No. Suppl 1 ( 2020-06), p. 875.1-876
    Abstract: Immune checkpoint inhibitors (ICIs) have improved cancer therapy and especially clinical outcomes for patients with many malignancies [ 1 ]. ICIs lead to a higher immune system activity and subsequent attack of tumor cells. However, this effect can cause rheumatological immune related adverse events (rh-irAE), which have not yet been extensively studied. Objectives: To determine the prevalence and type of rh-irAE in patients treated with ICIs. Additionally, our study focused on duration, severity and therapy of rh-irAE as well as the correlation between tumor response rate and patients with or without rh-irAE. Methods: We analysed 437 patients between January 2014 and October 2019, treated with ipilimumab (anti-CTLA-4) and/ or nivolumab (anti-PD-1) or pembrolizumab (anti-PD-1) at the Department of Oncology, Hematology and Rheumatology at the University Hospital in Bonn, Germany. Results: Of the 437 patients, 260 (60%) were males, 177 (40%) were females with a mean age of 64 years (SD ± 14) at the beginning of the ICI-therapy. 152 patients (34.8%) displayed at least one irAE. We identified 20 patients (4.6%) with a minimum of one rh-irAE due to ICI-therapy, seven of those had a pre-existing rheumatological disease. Those 20 patients were initially treated for melanoma, lung cancer, head and neck tumor and gastrointestinal carcinoma. Rh-irAE occurred in one patient (2.6%) with ipilimumab, in nine patients (4.8%) with nivolumab, in nine patients (5.7%) with pembrolizumab and in one patient (1.9%) with a combination of ipilimumab and nivolumab. Arthralgia developed most frequently in nine of the 20 patients (45%). Arthritis and myositis occurred with equal frequencies, in three cases each (3 patients, 15%). Furthermore, three of the 20 patients (15%) developed a psoriatic arthritis and one patient (5%) osteoarthritis. The time to the first rh-irAE after exposure to ICIs was in median 100 days (IQR 45 – 406 days). Most rh-irAE were classified as moderate severe (CTCAE [Common Terminology Criteria of Adverse Events] grade 2: 55%). 15 patients (75%) were treated with systemic corticosteroids. In three cases (15%) additional therapy with methotrexate and in one patient (5%) with tocilizumab was required. Other therapies including non-steroidal anti-inflammatory drugs and opioids were also used in eight patients. Even though patients benefited from ICI treatment, therapy had to be discontinued in nine of them (45%). Interestingly, patients with rh-irAE had a significantly higher tumor response rate compared to patients without any irAE (95% vs. 33%; p 〈 0,0001). Table 1. Independent risk factors of IFI in patients with SLE a Candidiasis Cryptococcosis Aspergillosis HR (95% CI) P value HR (95% CI) P value HR (95% CI) P value Age 〉 50 1.77 (1.27-2.47) 〈 0.001 Diabetes mellitus 1.65 (1.16-2.35) 0.006 End-stage renal disease 1.76 (1.29-2.41) 〈 0.001 Stroke 1.77 (1.26-2.47) 〈 0.001 1.96 (1.09-3.53) 0.024 Mycophenolate mofetil 2.72 (1.60-4.61) 〈 0.001 4.02 (1.32-12.26) 0.015 Cyclosporin 4.94 (1.61-15.10) 0.005 Cyclophosphamide 1.50 (1.07-2.10) 0.019 Intravenous steroid 28.19 (21.17-37.52) 〈 0.001 63.51 (36.10-111.71) 〈 0.001 34.80 (15.09-80.24) 〈 0.001 a All factors with P 〈 0.05 in univariate analysis were selected for Cox multivariate analysis. CI, confidence interval; HR, hazard ratio. Figure 1. Incidence rate and incidence rata ratio of invasive fungal infection Figure 2. Kaplan-Meier curve of invasive fungal infection-free status in SLE versus non-SLE group. Conclusion: Our results show, that rh-irAE occur under ICI-therapy and in patients with higher tumor response. However, they are not the most frequent irAE after ICI exposure: 10.2% of all irAE were rheumatological (22 rh-irAE cases in 20 patients of a total of 216 irAE cases in 152 patients). As the use of ICIs is increasing for different malignancies the incidence of rh-irAE can be expected to increase. References: [1] Ribas A, Wolchok JD. Cancer immunotherapy using checkpoint blockade. Science . 2018;359(6382):1350-1355. doi:10.1126/science.aar4060 [2] Spain L, Diem S, Larkin J. Management of toxicities of immune checkpoint inhibitors. Cancer Treat Rev . 2016;44:51-60. doi:10.1016/j.ctrv.2016.02.001 Acknowledgments Disclosure of Interests: None declared
    Type of Medium: Online Resource
    ISSN: 0003-4967 , 1468-2060
    RVK:
    Language: English
    Publisher: BMJ
    Publication Date: 2020
    detail.hit.zdb_id: 1481557-6
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 8
    Online Resource
    Online Resource
    BMJ ; 2021
    In:  Annals of the Rheumatic Diseases Vol. 80, No. Suppl 1 ( 2021-06), p. 920.1-920
    In: Annals of the Rheumatic Diseases, BMJ, Vol. 80, No. Suppl 1 ( 2021-06), p. 920.1-920
    Abstract: The European League Against Rheumatism (EULAR) recommends using ultrasound (US) in patients with rheumatoid arthritis and psoriatic arthritis in diagnosis (1). In addition, US examination is crucial for detecting enthesitis in the above mentioned rheumatic diseases. However, abnormal findings on US may also occur in healthy individuals as indicated by recent studies focusing on small joints like metacarpophalangeal joint, metatarsophalangeal joint or the elbow. (2,3) Ultrasound assessment of large joints in healthy individuals has not been extensively studied so far, causing a lack of information concerning normal values in musculoskeletal US examination. Objectives: The purpose of this study was to determine the prevalence of joint effusion, hyperperfusion of the synovia and enthesitis in large and medium-sized joints of healthy individuals. Methods: Ultrasound assessment of shoulder, elbow, wrist, hip, knee and ankle joints as well as corresponding entheseal sites including the Achilles tendon and the plantar aponeurosis was performed in healthy individuals below the age of 30 years. Additionally, participants filled out a survey on their physical activity level, underwent a bioelectrical impedance analysis (BIA) and conducted a supervised weight training to determine their training volume. Prevalence of US findings was calculated, and a binary logistic regression model was applied to determine the association between the present findings and sex, age, handedness, hours of sports activity per week, BMI, amount of skeletal muscle mass (SMM) or training volume of strength training. Results: We included 51 healthy individuals with a mean age of 23.7 years, 52.9% were female with a mean BMI of 22.5 kg/m 2 . Ultrasound examination detected joint effusion in one joint in 25.5% (n=13), 29.4% (n=15) showed effusion in two of twelve examined joints. Joint effusion in three, four and five joints was detected in 9.8% (n=5), 3.9% (n=2) and 3.9% (n=2) of the cases, respectively. In 27.5% (n=14) of the individuals no joint effusion was observed. The most frequently affected joint was the elbow joint. Synovial hyperperfusion was not detected in any participant. Enthesitis was observed in one, two and three examined entheseal sites in 19.5% (n=10), 5.9% (n=3) and 2% (n=1), respectively. In 72% (n=37) of the examined individuals no pathology of the entheseal sites was found. Hyperperfusion presented to be the most frequent pathology observed in enthesitis (23%), followed by calcification (6%). Binary logistic regression model demonstrated a significant association between reported hours of sports activity per week and the prevalence of effusion in the knee (p = 0.017). The odds of joint effusion in the knee increased with the hours of sports activity by 34.1% (Exp(B)= 1.341, 95%-CI(1.054, 1.705)). Additionally, the odds of enthesitis in any entheseal site increased with BMI (p= 0.015, Exp(B) = 1.407, 95%-CI(1.068, 1.852). Binary logistic regression model did not show any significant association between sex, age, handedness, amount of SMM or training volume of strength training and the prevalence of joint effusion or enthesis pathology in the examined participants. Conclusion: Joint effusion in large and mid-sized joints as well as enthesitis are not only detected in patients with rheumatic diseases but also in healthy individuals. Hours of sports activity and BMI have a significant association with the findings and should be considered during ultrasound examination. References: [1]Colebatch AN, Edwards CJ, Østergaard M, van der Heijde D, Balint PV, D’Agostino M-A, u. a. EULAR recommendations for the use of imaging of the joints in the clinical management of rheumatoid arthritis. Ann Rheum Dis. Juni 2013;72(6):804–14. [2]Padovano I, Costantino F, Breban M, D’Agostino MA. Prevalence of ultrasound synovial inflammatory findings in healthy subjects. Ann Rheum Dis. Oktober 2016;75(10):1819–23. [3]Schäfer VS, Recker F, Vossen D, Ge I, Matuschek E, Hartung W. Prevalence of Elbow Joint Arthritis and Enthesitis in Rheumatoid Arthritis. 2020;11. Disclosure of Interests: Julia Konstanze Schreiner: None declared, Dennis Scheicht: None declared, Pantelis Karakostas: None declared, Charlotte Behning: None declared, Peter Preuss: None declared, Peter Brossart: None declared, Valentin Schäfer Speakers bureau: AbbVie, Novartis, BMS, Chugai, Celgene, Medac, Sanofi, Lilly, Hexal, Pfizer, Janssen, Roche, Schire, Onkowissen, Royal College London, Consultant of: Novartis, Chugai, AbbVie, Celgene, Sanofi, Lilly, Hexal, Pfizer, Amgen, BMS, Roche, Gilead, Medac, Grant/research support from: Novartis, Hexal, Lilly, Roche, Celgene, Universität Bonn
    Type of Medium: Online Resource
    ISSN: 0003-4967 , 1468-2060
    RVK:
    Language: English
    Publisher: BMJ
    Publication Date: 2021
    detail.hit.zdb_id: 1481557-6
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 9
    Online Resource
    Online Resource
    Springer Science and Business Media LLC ; 2014
    In:  Bone Marrow Transplantation Vol. 49, No. 2 ( 2014-02), p. 179-184
    In: Bone Marrow Transplantation, Springer Science and Business Media LLC, Vol. 49, No. 2 ( 2014-02), p. 179-184
    Type of Medium: Online Resource
    ISSN: 0268-3369 , 1476-5365
    RVK:
    RVK:
    Language: English
    Publisher: Springer Science and Business Media LLC
    Publication Date: 2014
    detail.hit.zdb_id: 2004030-1
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 10
    In: Annals of the Rheumatic Diseases, BMJ, Vol. 81, No. Suppl 1 ( 2022-06), p. 21.2-22
    Abstract: The early diagnosis of psoriatic arthritis (PsA) requires a close interdisciplinary cooperation between rheumatology and dermatology. Recent publications underlined the key role of dermatologists in this process (1). Despite available screening tools like questionnaires, there is a need to increase sensitivity and specificity of diagnostic screening tools for PsA. Musculoskeletal ultrasonography (MSUS) has been shown to be a reliable tool for diagnosing PsA, even in preclinical situations. However, the use of MSUS screening by dermatologists in the early detection of PsA has not been studied so far. Objectives The purpose of this study was to assess the accuracy of early PsA identification by dermatologists who have been previously trained in MSUS utilizing an innovative handheld-ultrasound device (Butterfly IQ). Methods Twelve dermatologists have been trained in MSUS (2) previously by a newly designed curriculum. Six working at the clinic for Dermatology and Allergology of the University Hospital Bonn, while the remaining six serve in private practices. The MSUS training curriculum focused mainly on detecting joint effusion and synovial hyperperfusion in all joints. After successful training, these colleagues were provided with handheld-ultrasound devices in order to screen 140 psoriasis patients presenting with arthralgia. Dermatologists were asked to determine whether or not the patient had PsA based on the medical history, clinical examination, and GEPARD questionnaire. Subsequently a MSUS exam of up to three painful joints was conducted by the dermatologists using the provided handheld-ultrasound devices. The post MSUS decision was also recorded. All prescreened patients were then referred to blinded board-certified rheumatologists with MSUS certification (EFSUMB level II and III), which repeated medical history, clinical examination and MSUS. We investigated the impact of MSUS on the sensitivity and specificity of early PsA diagnosis by comparing dermatologists’ pre- and post-ultrasound PsA suspicion with the final diagnosis determined by the rheumatologist. Results In total, 140 patients were enrolled. PsA was detected in 24 cases. The sensitivity of dermatologists’ pre-MSUS PsA suspicion was 81.0 %, while the specificity was 54.5 %. After conducting MSUS the sensitivity and specificity changed to 61.9% and 90.9%, respectively. The MSUS findings lead the dermatologists to change their presumed PsA diagnosis in 46 cases, with PsA being ruled out in 45 of them. Conclusion We were able to demonstrate that targeted MSUS performed by dermatologists increases specificity while decreasing sensitivity, perhaps leading to fewer referrals to rheumatologists and an earlier diagnosis of PsA. References [1]McHugh NJ. Verna Wright Lecture: Psoriatic Arthritis: The Need for Early Intervention. J Rheumatol. 2015; 93:10 – 13. [2]Grobelski J, Recker F, Theis DW-, et al. Establishment and validation of a didactic musculoskeletal ultrasound course for dermatologists using an innovative handheld ultrasound system – the MUDE study (Musculoskeletal Ultrasound in Dermatology). JDDG: Journal der Deutschen Dermatologischen Gesellschaft 2021;19:1753–9. Disclosure of Interests None declared.
    Type of Medium: Online Resource
    ISSN: 0003-4967 , 1468-2060
    RVK:
    Language: English
    Publisher: BMJ
    Publication Date: 2022
    detail.hit.zdb_id: 1481557-6
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...